Heart failure

...into the appropriate areas of the patient's heart muscle using a specialized catheter. About Ischemic Heart Failure Ischemic heart failure is caused by an obstruction of the arteries feeding blood to the heart tissue. The resulting...

In this article: Aldagen, Medical advice, Oxygen, Revascularization, and Aldehyde dehydrogenase

ORLANDO A new study suggests that thousands of heart failure deaths and hospitalizations may be averted each year if doctors prescribe higher doses of a critical medication, researchers here said Tuesday. The medication, called an...

In this article: ACE Inhibitor, Vytorin, Zetia, Beta blocker, Mayo Clinic, and USA Today

Article Date: 18 Nov 2009 - 5:00 PST Most heart failure patients who develop kidney failure in the hospital do not recover from it before going home and are at increased risk of either being re-hospitalized or dying within the year,...

In this article: Henry Ford Hospital, Oxygen, Heart transplant, and Orlando

Article Date: 18 Nov 2009 - 3:00 PST A larger dose of angiotensin receptor blockers (ARBs) is more effective than a smaller dose in heart failure patients, researchers said at the American Heart Association's Scientific Sessions 2009.

In this article: Losartan

TUESDAY, Nov. 17 (HealthDay News) -- For people with heart failure, high doses of the drug losartan, an angiotensin-receptor blocker (ARB), reduce the risk for hospital admission and death, a new study shows. Though ARBs are known to...

In this article: Losartan, The Lancet, Potassium, Hyperkalemia, and Tufts University School of Medicine

...Fla., meeting of the American Heart Assn. showed that a new type of device more than doubled the two-year survival rate among heart failure patients. The key to the improvement was the development of a smaller, quieter, more reliable pump...

In this article: Surgery, Orlando, Fla, United States, American College of Cardiology, University of Louisville, and Food and Drug Administration

...first time, a miniature heart pump shows the potential to become a widely used, permanent treatment for many older people with severe heart failure. But can we afford it? In a study of 200 patients, the new device increased by four times the...

In this article: Surgery, New England Journal of Medicine, Breast cancer, American College of Cardiology, Stroke, University of Louisville, and Temple University

...Assn. show that one such device, manufactured by Thoratec Corp. of Pleasonton and called the HeartMate II, doubled the two-year survival of heart failure patients compared with the older pulsing pump. The device is currently approved by the...

In this article: Surgery, Orlando, Fla, American College of Cardiology, University of Louisville, Los Angeles Times, and Food and Drug Administration

ORLANDO, Fla. -- Doctors say that a new type of heart pump greatly improves survival of people with severe heart failure. It could become the first one of these devices to be widely used as a permanent treatment. The device is implanted...

In this article: New England Journal of Medicine, Surgery, Stroke, Steven Nissen, Cleveland Clinic, and Pleasanton